Mesoblast (MESO)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from MESO's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Mesoblast's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $7M | $10M | $8M | $6M | $17M |
| Net income | -$99M | -$91M | -$82M | -$88M | -$102M |
| Free cash flow | -$101M | -$66M | -$64M | -$49M | -$51M |
| EPS (diluted) | -$0.16 | -$0.13 | -$0.11 | -$0.09 | -$0.08 |
| Operating margin | — | — | — | — | — |
Superinvestors who own MESO
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Trimmed | $341,267 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Mesoblast's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Apr 10, 2026 | Gregory George Director |
2,324,072 | $1.48 | $3M |
| Apr 9, 2026 | Gregory George Director |
1,586,890 | $1.44 | $2M |
| Apr 9, 2026 | Gregory George Director |
1,981,890 | $8.59 | $17M |
| Apr 4, 2026 | Gregory George Director |
4,000,000 | $1.42 | $6M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when MESO trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Mesoblast insiders buying the stock?
4 open-market insider purchases of MESO in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Mesoblast?
1 of the superinvestors Investingly tracks hold MESO in their latest 13F, including Cliff Asness.
Companies like Mesoblast
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.